Showing results (1211-1220 of 1,437) with videos related to

Sort By:
Pageof 144
Blood Reviews|April 29, 2022
Harnessing the power of sphingolipids: Prospects for acute myeloid leukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Nature Genetics|February 5, 2013
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemiaJulia A Meyer, Jinhua Wang, Laura E Hogan, et al.
The Journal of Experimental Medicine|August 3, 2016
Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosisSrdan Verstovsek, Taghi Manshouri, Darrell Pilling, et al.
Blood|February 16, 2010
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosisPriya Koppikar, Omar Abdel-Wahab, Cyrus Hedvat, et al.
Blood|September 25, 2010
Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trialEdward A Stadtmauer, Dan T Vogl, Eline Luning Prak, et al.
JCI Insight|July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaMarlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2020
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic LeukemiaNoelle V Frey, Saar Gill, Elizabeth O Hexner, et al.
Blood|November 14, 2015
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effectClaudio G Brunstein, Jeffrey S Miller, David H McKenna, et al.
The Journal of Clinical Investigation|March 17, 2009
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse modelThomas Mercher, Glen D Raffel, Sandra A Moore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative NeoplasmsRaajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.
Pageof 144